Annual Drug Patent Expirations for KALETRA Kaletra is a drug marketed by Abbvie and is included in three NDAs. It is available from three suppliers. KALETRA drug price trends. Drug…
The post Patent delisted for Abbvie drug KALETRA appeared first on Dru…
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from three suppliers. There are thirteen patents…
The post Patent delisted for Helsinn Hlthcare drug ALOXI appeared first…
Annual Drug Patent Expirations for BENICAR+HCT Benicar Hct is a drug marketed by Daiichi Sankyo and is included in one NDA. It is available from three suppliers. BENICAR HCT drug…
The post Patent delisted for Daiichi Sankyo drug BENICAR HCT appeared fi…
Patent delisted for Daiichi Sankyo drug BENICAR HCT Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post Patent delisted for Astrazeneca Ab drug BYDUREON appeared first…
Patent delisted for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appear…
Patent delisted for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…
DEXYCU KIT (dexamethasone) Eyepoint pharms Patent: 10,022,502 Expiration: Sep 12, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dru…
Drug Patent Expirations for the Week of September 6, 2020 Read Post »
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fifteen…
The post Patent delisted for Boehringer Ingelheim drug TRIJARDY XR a…
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post Patent delisted for Boehringer Ingelheim drug OFEV appeared first on…
Patent delisted for Boehringer Ingelheim drug OFEV Read Post »
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are eleven patents…
The post Patent delisted for Boehringer Ingelheim drug GLYXAMBI ap…
Patent delisted for Boehringer Ingelheim drug GLYXAMBI Read Post »